ANCA-Associated Vasculitis: Parsing the Kidney Complications
Bearing in mind that renal impairment is among the worst complications of ANCA-associated…
Browsing Tag
ANCAAssociated
ANCA-Associated Vasculitis: Novel Biologic Shows Promise for Replacing Steroids
PHILADELPHIA -- An investigational monoclonal antibody targeting C5a complement, when partially or fully substituted for…
FDA Gives Thumbs Up to ANCA-Associated Vasculitis Drug
The FDA approved the oral complement 5a receptor inhibitor avacopan (Tavneos) for the treatment…
ChemoCentryx Announces FDA Approval of TAVNEOS™ (avacopan) in ANCA-Associated…
-- First FDA-approved orally-administered inhibitor of the complement 5a receptor -- -- Company to hold conference call at 8:30 a.m. Eastern Time -- SAN CARLOS, Calif., Oct. 08, 2021…
ChemoCentryx Announces Approval in Japan of TAVNEOS™ (Avacopan) for the Treatment of…
SAN CARLOS, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Kissei Pharmaceutical Co., Ltd. has received approval from the Japanese…